MYC表达与ALK阳性间变性大细胞淋巴瘤患者年龄较大、常见形态、MYC拷贝数增加及预后较差相关
该研究首次评估MYC表达在ALK阳性间变性大细胞淋巴瘤中的临床病理及预后意义。采用免疫组化以≥50%为阳性 cutoff,46例中17例(37%)为MYC阳性;MYC阳性者年龄更大(中位39 vs 29岁,p=0.04)且更常见普通形态(100% vs 69%,p=0.02)。FISH显示31例中9例(29%)MYC拷贝数增加,1例(3%)有MYC重排,21例(68%)无MYC异常;MYC表达与拷贝数增加相关(p=0.01)。MYC表达(而非拷贝数增加)与较短总生存相关(p=0.03)。
要点
- MYC免疫组化≥50%阳性在ALK+ ALCL中占37%,阳性者年龄更大且多为普通形态。
- MYC表达与MYC拷贝数增加相关,但仅MYC表达与较短总生存相关。
- MYC表达可能是ALK+ ALCL的不良预后因素,有助于风险分层。
核心结论
- MYC表达识别出一组行为更具侵袭性且总生存较短的ALK+ ALCL患者。
- MYC表达是不良预后因素,可能有助于分层或预测ALK+ ALCL患者预后。
研究设计与样本
- 回顾性评估46例ALK+ ALCL病例的MYC免疫组化表达及临床病理特征。
- 采用≥50%作为免疫组化MYC阳性的 cutoff 值。
- 对31例进行FISH分析MYC拷贝数及重排。
主要发现
- 46例中17例(37%)为MYC阳性。
- MYC阳性患者中位年龄39岁 vs 阴性29岁(p=0.04)。
- MYC阳性者普通形态占100% vs 阴性69%(p=0.02)。
- 31例中9例(29%)MYC拷贝数增加,1例(3%)MYC重排,21例(68%)无MYC异常。
- MYC表达与MYC拷贝数增加相关(p=0.01),MYC表达与较短OS相关(p=0.03)。
关键数值与推荐
- MYC免疫组化阳性 cutoff 值为≥50%。
- 拷贝数增加病例中,5/8(62%)为MYC拷贝获得和/或扩增,3/8(38%)为8号染色体多体。
临床怎么用
- 对ALK+ ALCL患者可检测MYC免疫组化表达以辅助预后分层。
- MYC表达阳性提示侵袭性行为及较短生存,需更密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of MYC dysregulation has been studied extensively in B-cell lymphomas, but little is known about its significance in T cell lymphomas. This study, for the first time in the literature, assessed the clinicopathologic and prognostic significance of MYC expression in ALK+ anaplastic large cell lymphoma (ALCL) cases. Using ≥50% as the cutoff value for positive MYC expression by immunohistochemistry, 17 of 46 (37%) cases were MYC+. Patients with MYC+ tumors were older (median age, 39 versus 29 years, p = 0.04) and more often showed a common morphologic pattern (100% versus 69%, p = 0.02), when compared with those with MYC-negative tumors. By fluorescence in situ hybridization analysis, 9 of 31 (29%) cases showed increased MYC copy number, and 1 of 31 (3%) case had an MYC rearrangement, and the remaining 21 (68%) cases showed no MYC aberrations. Among the cases with increased MYC copy number, 5 of 8 (62%) cases showed MYC copy gain and/or amplification and 3 of 8 (38%) had polysomy 8. MYC expression was associated with increased MYC copy number (p = 0.01). MYC expression, but not increased MYC copy number, correlated with shorter overall survival (OS) (p = 0.03). In conclusion, MYC expression identified a distinct group of ALK + ALCL patients with more aggressive behavior and shorter OS. Our data suggest that MYC expression is an adverse prognostic factor and may be useful in stratifying or predicting the prognosis of patients with ALK+ ALCL.
引用
- Lyapichev KA, Tang G, Li S, et al. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol. 2020. PMID: 33221344. doi:10.1016/j.humpath.2020.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。